desentum
Espoo, FI · Founded 2011 · 14 employees on LinkedIn · 1 known investors
Find your way into desentum
80 people in our graph can introduce you to the desentum team.
Sign up to see every warm intro you have to desentum
- Paths you didn't know you had: your email and LinkedIn already hold routes to the desentum team. We find them
- 2nd- and 3rd-degree connections: the friend-of-a-friend routes you can't see from your own inbox or LinkedIn
- Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone
Days of research, done the moment you sign in, with every route ranked by how warm it is.
Desentum is a clinical-stage biopharmaceutical company developing allergen immunotherapy products that reprogram immune responses to allergens toward tolerance. The company targets both respiratory and food allergies, with its lead asset currently in phase II clinical trials.
Founders & leadership
desentum was founded in 2011 by Juha Rouvinen and Kristiina Takkinen.
JR

Juha RouvinenCo-founder
KT

Kristiina TakkinenCo-founder
PM

Pekka MattilaCEOPekka Mattila founded Finnzymes Group in 1987, serving as its CEO until 2010, and later held a site leadership role at Thermo Fisher Scientific. He holds a background in biochemistry and molecular biology from Helsinki University of Technology, where he worked as a research group leader in the chemistry department.
Board
HS
Hans SöderlundChairman of the Board
Investors · 1
Frequently asked questions
- What does desentum do?
- Desentum is a clinical-stage biopharmaceutical company developing allergen immunotherapy products that reprogram immune responses to allergens toward tolerance. The company targets both respiratory and food allergies, with its lead asset currently in phase II clinical trials.
- Who founded desentum?
- desentum was founded by Juha Rouvinen, Kristiina Takkinen in 2011.
- Who are desentum's investors?
- desentum's investors include Voima Ventures.
- Where is desentum headquartered?
- desentum is headquartered in Espoo, FI.

